Lupin Limited appoints Abdelaziz Toumi as CEO of new subsidiary

Pallavi Madhiraju- June 18, 2024 0

Global pharmaceutical giant, Lupin Limited, announced the appointment of Abdelaziz Toumi (commonly known as Abdel) as the Chief Executive Officer of its newly established subsidiary, ... Read More

Strides Pharma Science gets FDA approval for Fluoxetine Tablets for depressive disorders

Pallavi Madhiraju- April 9, 2024 0

Strides Pharma Science Limited (Strides) has made a notable advancement in the field of mental health treatment by securing approval from the United States Food ... Read More

Gland Pharma receives USFDA approval for first generic Eribulin Mesylate Injection

Pallavi Madhiraju- April 7, 2024 0

In a significant advancement for generic pharmaceuticals, Gland Pharma Limited, a company specializing in generic injectable-focused pharmaceutical products, has announced receiving approval from the United ... Read More

Zydus Lifesciences announces WHO approval for NLRP3 inhibitor Usnoflast

Pallavi Madhiraju- April 1, 2024 0

Zydus Lifesciences, a discovery-based, global pharmaceutical leader, has recently received approval from the World Health Organization (WHO) International Non-proprietary Names (INN) for "Usnoflast" as the ... Read More

Zydus Lifesciences receives tentative FDA approval for Letermovir tablets

Pallavi Madhiraju- March 24, 2024 0

In a significant development for patients undergoing bone marrow or kidney transplants, Zydus Lifesciences Limited has been granted tentative approval by the United States Food ... Read More

Gilead Sciences completes $4.3bn acquisition of CymaBay Therapeutics to enhance liver disease portfolio

Pallavi Madhiraju- March 23, 2024 0

Gilead Sciences, Inc. (Nasdaq: GILD) has officially announced the successful acquisition of CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for a staggering $4.3 billion, a move that ... Read More

Aurobindo Pharma gains FDA approval for Mometasone Furoate Monohydrate Nasal Spray

Pallavi Madhiraju- March 19, 2024 0

In a major development within the pharmaceutical industry, Aurobindo Pharma Limited (Aurobindo) announced it has received final approval from the US Food & Drug Administration ... Read More

Venus Remedies receives significant boost with PLI Scheme disbursement

Pallavi Madhiraju- March 6, 2024 0

Venus Remedies Ltd, a leading player in India's generic drug manufacturing sector, has recently been awarded a pivotal disbursement of Rs 7.5 crore under the ... Read More